Results 161 to 170 of about 5,633 (190)

Febuxostat

Hospital Pharmacy, 2009
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing ...
Dennis J. Cada, Terri L. Levien, Danial E. Baker   +2 more
openaire   +2 more sources

Febuxostat

Reactions Weekly, 2017
  +7 more sources

Febuxostat

Reactions Weekly
  +8 more sources

Febuxostat

Reactions Weekly, 2018
  +7 more sources

Febuxostat

DMW - Deutsche Medizinische Wochenschrift, 2011
K, Wittköpper, J, Emons, A, El-Armouche
openaire   +3 more sources

Febuxostat

Practical Diabetes, 2013
S Haris Ahmed, Louisa M Bethell
openaire   +2 more sources

Febuxostat

Reactions Weekly, 2022
  +4 more sources

Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis

Clinical Cardiology, 2021
Linggen Gao, Ying Pan, Rui Cheng
exaly  

Febuxostat

Reactions Weekly, 2021
openaire   +1 more source

Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

Lancet, The, 2020
Isla S Mackenzie, Stuart H Ralston, Matthew Walters   +2 more
exaly